MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced that it has received approval from the United States Food and Drug Administration to market the E•Luminexx TM Vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results